Entheon Biomedical Corp.
ENTBF
$0.00
$0.000.00%
OTC PK
| 02/28/2026 | 11/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 37.18% | 30.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 37.18% | 30.77% | |||
| Operating Income | -37.18% | -30.77% | |||
| Income Before Tax | -56.87% | -35.86% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -56.87% | -35.86% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -56.87% | -35.86% | |||
| EBIT | -37.18% | -30.77% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -2.94% | -36.00% | |||
| Normalized Basic EPS | -4.76% | -40.00% | |||
| EPS Diluted | -2.94% | -36.00% | |||
| Normalized Diluted EPS | -4.76% | -40.00% | |||
| Average Basic Shares Outstanding | 48.72% | -0.01% | |||
| Average Diluted Shares Outstanding | 48.72% | -0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||